- Home
- SUPN vs APLD Comparison
SUPN vs APLD Comparison
Compare SUPN & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- APLD
- Stock Information
- Founded
- SUPN 2005
- APLD 2001
- Country
- SUPN United States
- APLD United States
- Employees
- SUPN N/A
- APLD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- APLD Investment Bankers/Brokers/Service
- Sector
- SUPN Health Care
- APLD Finance
- Exchange
- SUPN Nasdaq
- APLD Nasdaq
- Market Cap
- SUPN 1.8B
- APLD 1.3B
- IPO Year
- SUPN 2012
- APLD N/A
- Fundamental
- Price
- SUPN $33.18
- APLD $9.18
- Analyst Decision
- SUPN Hold
- APLD Strong Buy
- Analyst Count
- SUPN 2
- APLD 11
- Target Price
- SUPN $36.00
- APLD $12.64
- AVG Volume (30 Days)
- SUPN 790.6K
- APLD 36.3M
- Earning Date
- SUPN 08-05-2025
- APLD 08-27-2025
- Dividend Yield
- SUPN N/A
- APLD N/A
- EPS Growth
- SUPN N/A
- APLD N/A
- EPS
- SUPN 1.11
- APLD N/A
- Revenue
- SUPN $667,997,000.00
- APLD $221,192,000.00
- Revenue This Year
- SUPN N/A
- APLD $34.51
- Revenue Next Year
- SUPN $12.02
- APLD $3.33
- P/E Ratio
- SUPN $29.94
- APLD N/A
- Revenue Growth
- SUPN 11.82
- APLD 53.70
- 52 Week Low
- SUPN $26.65
- APLD $3.01
- 52 Week High
- SUPN $40.28
- APLD $15.42
- Technical
- Relative Strength Index (RSI)
- SUPN 60.49
- APLD 45.01
- Support Level
- SUPN $31.35
- APLD $9.13
- Resistance Level
- SUPN $33.80
- APLD $9.64
- Average True Range (ATR)
- SUPN 0.92
- APLD 0.69
- MACD
- SUPN 0.16
- APLD -0.29
- Stochastic Oscillator
- SUPN 79.12
- APLD 8.25
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.